This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen acción BLR
BLIRT S.A. engages in the manufacture and sale of recombinant enzymes for the life science industry.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de BLIRT S.A.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | zł14.90 |
| 52 Week High | zł15.90 |
| 52 Week Low | zł6.20 |
| Beta | -1.65 |
| 1 Month Change | 0% |
| 3 Month Change | 65.56% |
| 1 Year Change | 5.08% |
| 3 Year Change | 2,157.58% |
| 5 Year Change | 1,121.31% |
| Change since IPO | 127.48% |
Noticias y actualizaciones recientes
Recent updates
Market Cool On BLIRT S.A.'s (WSE:BLR) Earnings Pushing Shares 26% Lower
Oct 02
BLIRT S.A. (WSE:BLR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 02BLIRT's (WSE:BLR) Earnings Are Of Questionable Quality
May 19Will Weakness in BLIRT S.A.'s (WSE:BLR) Stock Prove Temporary Given Strong Fundamentals?
Jan 14
With EPS Growth And More, BLIRT (WSE:BLR) Is Interesting
Dec 09Rentabilidad de los accionistas
| BLR | PL Biotechs | Mercado PL | |
|---|---|---|---|
| 7D | 0% | 4.0% | -1.9% |
| 1Y | 5.1% | -18.4% | 27.3% |
Rentabilidad vs. Industria: BLR exceeded the Polish Biotechs industry which returned -30.9% over the past year.
Rentabilidad vs. Mercado: BLR exceeded the Polish Market which returned -23.4% over the past year.
Volatilidad de los precios
| BLR volatility | |
|---|---|
| BLR Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 4.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Precio estable de las acciones: BLR's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine BLR's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1994 | 75 | Thierry Bernard | www.blirt.eu |
Resumen de fundamentos de BLIRT S.A.
| Estadísticas fundamentales de BLR | |
|---|---|
| Capitalización bursátil | zł261.14m |
| Beneficios(TTM) | zł7.57m |
| Ingresos (TTM) | zł39.77m |
34.5x
Ratio precio-beneficio (PE)6.6x
Ratio precio-ventas (PS)¿Está BLR sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de BLR | |
|---|---|
| Ingresos | zł39.77m |
| Coste de los ingresos | zł5.68m |
| Beneficio bruto | zł34.09m |
| Otros gastos | zł26.52m |
| Beneficios | zł7.57m |
Últimos beneficios comunicados
Dec 31, 2021
Próxima fecha de beneficios
Aug 11, 2022
| Beneficios por acción (BPA) | 0.43 |
| Margen bruto | 85.72% |
| Margen de beneficio neto | 19.02% |
| Ratio deuda/patrimonio | 0.001% |
¿Cómo se ha desempeñado BLR a largo plazo?
Ver rendimiento histórico y comparativa